VS

Vidya Salunke Sudhir

Director DIN 05279373
DIN 05279373 First appointment Dec 2012
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Vidya Salunke Sudhir

Data last updated:

Vidya Salunke Sudhir was a Director at Nulife Multispeciality Hospital Private Limited (from 2012) and Director at Medicraft Pharmaceuticals Private Limited (from 2013).

DIN 05279373
First Appointment 12 Dec 2012
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Dec 20122012Strike Off
Director06 Jan 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nulife Multispeciality Hospital Private Limited
Medicraft Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vidya Salunke Sudhir

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vidya Salunke Sudhir

Vidya Salunke Sudhir was first appointed on 12 Dec 2012 as Director at Nulife Multispeciality Hospital Private Limited. The most recent appointment on record is 06 Jan 2013 at Medicraft Pharmaceuticals Private Limited.

Vidya Salunke Sudhir held 2 earlier board appointments: Nulife Multispeciality Hospital Private Limited (Director, from 12 Dec 2012); Medicraft Pharmaceuticals Private Limited (Director, from 06 Jan 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available